Knowledge · Natural Compounds

Biotin (Vitamin B7)

Biotin is a water-soluble B vitamin; human studies found lower total cholesterol in type 2 diabetes and mixed findings for hair, skin, nails and multiple sclerosis.

Last updated:

We evaluated 123 human studies on Biotin (Vitamin B7), including 12 randomised controlled trials and 6 meta-analyses or systematic reviews; the controlled studies include 1,170 participants in total. As of 11 October 2026.

This page as PDF · Summary

1. What Is Biotin (Vitamin B7)? Occurrence, Origin and Forms

Biotin is a water-soluble vitamin of the B group. In the body it acts as a coenzyme of several carboxylases involved in fat, carbohydrate and protein metabolism. As a supplement it is traditionally associated with hair, skin and nails, and medically it is given in confirmed biotin deficiency and in inborn disorders of biotin metabolism.

Biotin occurs in many foods, among them egg yolk, liver, nuts, oats, soy and yeast, and is additionally produced by gut bacteria. In body cells it is present bound to protein.

In foods biotin is bound to protein and is released in the gut by the enzyme biotinidase. In supplements it is present in free form; human studies examine free biotin taken by mouth, high-dose biotin and biotin as a component of combination products, and in metabolic medicine also biotin as an infusion.

Forms and Preparations Studied

  • Biotin from foods, bound to protein
  • Free biotin as a dietary supplement (tablets, capsules, drops)
  • High-dose biotin as used in studies of neurological disease
  • Biotin in combination products with other vitamins and minerals
  • Biotin for injection or infusion in inborn metabolic disorders

Not covered on this page:

  • Other B vitamins such as thiamine, riboflavin, pantothenic acid, folate and cobalamin are substances in their own right, even when they occur in the same products.
  • Combination products for hair, skin and nails that contain zinc, selenium or amino acids alongside biotin are not studies of biotin alone.
  • Interference of laboratory tests by biotin, for instance in immunoassays, is an analytical safety topic and not an area of application.

2. What Does Biotin (Vitamin B7) Do? Results by Area

AreaResult in controlled studiesStrength of evidenceStudiesParticipants
Biotin deficiencymostly improvedmoderate0 meta-analyses · 3 controlled · 24 other128
Multiple sclerosismostly no differencelow2 meta-analyses · 2 controlled · 20 other247
Hair lossmixedunclear1 meta-analyses · 2 controlled · 9 other165
Skin and skin inflammationmostly no differenceunclear0 meta-analyses · 2 controlled · 5 other165
Glucose and lipid metabolismmixedunclear1 meta-analyses · 1 controlled · 5 other40
Brittle nailsmixedunclear0 meta-analyses · 1 controlled · 2 other105
Other investigationsmostly no differenceunclear0 meta-analyses · 2 controlled · 51 other146

How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.

3. What the Studies Show in Detail

Biotin (Vitamin B7) and Biotin Deficiency: Human Studies

In pregnant women with increased excretion of 3-hydroxyisovaleric acid, a sign of mild biotin deficiency, this decreased with biotin in a randomized trial, while it increased slightly with placebo 15. In children with severe protein-energy malnutrition, the activity of biotin-dependent enzymes in lymphocytes increased with biotin, most strongly in those with initially low levels 20. The evidence is considered moderate, as both studies are small and involve different populations and outcome measures.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
10 Hanson et al. 2026randomised controlled · 80 participantsPrenatal multivitamin with 150 µg (intervention) or 30 µg (control) biotin; 150 µg vs. 30 µg biotin daily; 24 weeks; vs. Low-dose biotin (30 µg) in the same multivitaminPlasma 3HIA-carnitine: improved (p = 0.035)
15 Mock et al. 2002randomised controlled · 26 participantsBiotin supplement or placebo; 300 µg (1.2 µmol) biotin per day; 14 days; vs. Placebo-controlled, randomizedUrinary 3-HIA excretion (early pregnancy): improved (decreased (P < 0.006) by 11.7 +/- 3.6 mmol/mol creatinine); Urinary 3-HIA excretion (late pregnancy): improved (decreased (P < 0.002) by 7.1 +/- 1.2 mmol/mol creatinine)
20 Velázquez et al. 1995controlled · 22 participantsBiotin supplement; 10 mg/d; vs. Placebo, double-blindLymphocyte propionyl CoA carboxylase activity: unclear; Lymphocyte pyruvate carboxylase activity: unclear
22 Jezela-Stanek et al. 2022cross-sectional study · 1,071,463 participantsBiotinidase activity in dried blood spot and serum, BTD gene sequencingPrevalence of biotinidase deficiency (1:66,966 births, while 1:178,577 for profound and 1:107,146 for partial forms)
26 Upadia et al. 2025cohort study · 478 participantsNewborn screening for inborn errors of metabolism, including biotinidase deficiency; January 2005 to December 2024Incidence of inborn metabolic disorders: unclear (1 in 2574 live births); Most common condition: biotinidase deficiency: unclear
27 Sharma et al. 2024cross-sectional study · 407 participantsBiotinidase enzyme analysis and BTD gene sequencing; vs. enzyme activity <10% vs. >10% of mean normalenzyme activity <10% of mean normal: unclear (36 patients); most common variant in profound deficiency: unclear (c.528G>T); most common variant in activity >10%: unclear (c.1330G>C)
28 Yaralı et al. 2024cohort study · 357 participantsBiotin; vs. no control groupbiotinidase enzyme activity in homozygous p.D424His mutation: improved (above 30% in 97.3% of patients); prevention of symptoms with biotin treatment: improved (mild symptoms were effectively prevented)
29 Çıkı et al. 2024cross-sectional study · 302 participantsBiotin (endogenous, in biotinidase deficiency); vs. genotype-phenotype correlation, no intervention comparisongenotype-phenotype association in biotinidase deficiency: unclear

Further studies in this area: 30 35 41 45 49 50 52 61 62 65 77 79 83 84 86 91 99 103 107

Biotin (Vitamin B7) and Multiple Sclerosis: Human Studies

In multiple sclerosis, high-dose biotin (MD1003) has been tested against placebo in several randomized trials 7925. In a randomized trial in progressive MS, disability improved in some patients on high-dose biotin, and in none on placebo 7. EDSS progression was also lower 7. The follow-up study SPI2 did not confirm this benefit 25. Another randomized controlled trial showed no difference in visual acuity, retinal nerve fiber layer thickness, and quality of life in MS-related chronic vision loss 9. A systematic review with meta-analysis found no confirmed difference from placebo in disability and EDSS, but more often a faster walking time 1. The certainty of evidence is low: the first study showed benefit in some patients, but the follow-up study and the meta-analysis did not confirm this for disability. It remains open whether a subgroup benefits, for example in walking ability.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Espiritu et al. 2021meta-analysis · 889 participantsHigh-dose biotin (MD1003), oral, as adjunctive treatment; at least 300 mg/day; 12 to 15 months; vs. PlaceboComposite improvement of MS-related disability: no difference (RR 2.87; 95% CI 0.29-28.40); Improvement in expanded disability status scale: no difference (RR 2.27; 95% CI 0.25-20.98); Improvement in EDSS and 25-foot walk time: no difference (RR 0.58; 95% CI 0.17-2.00)
5 Marx et al. 2020systematic reviewBiotin as nutraceutical; vs. ControlBiological and/or clinical outcomes: unclear (1/2)
7 Tourbah et al. 2016randomised controlled · 154 participantsMD1003 (high-dose biotin); 100 mg biotin thrice daily; 12 months double-blind, then 12 months open-label for all; vs. PlaceboProportion with disability reversal (primary endpoint): improved (13 (12.6%) MD1003-treated patients achieved the primary endpoint versus none of the placebo-treated patients (p = 0.005)); EDSS progression: improved; Clinical impression of change: improved
9 Tourbah et al. 2018randomised controlled · 93 participantsMD1003 (high-dose pharmaceutical-grade biotin); 300 mg/day orally; 6 months double-blind, then 6 months open-label; vs. Placebo; manufacturer-fundedMean change in visual acuity (logMAR, 100% contrast) at 6 months: no difference (p = 0.66); 100% contrast VA in PON subgroup: no difference (p = 0.45); logMAR at 5% contrast: no difference
25 Joseph et al. 2026study · 506 participantsHigh-dose biotin vs. placebo (SPI2 trial), arms pooled; Follow-up over 27 months; vs. Pooled treatment arms, no efficacy analysisSerum NfL and daily step count: improved (IRR = 0.97, p = 0.014); 10% increase in steps and NfL z-score: improved (0.015 decrease in sNfL z-score (95% CI -0.022 to -0.008; p < 0.001)); Prior NfL increases and subsequent step count: unclear (β = -141; 95% CI -302 to 21; p = 0.088)
31 Pape et al. 2020cross-sectional study · 186 participantsvitamins and dietary supplements, including biotin; biotin 10 and 300 mg/day in healthy volunteers; vs. biotin intake vs. none; sNfL measurement with/without biotinfrequency of supplement intake: no difference (72.6%); interference of biotin with sNfL measurement: no difference
32 Couloume et al. 2020cohort study · 178 participantsHigh-dose biotin; 12 months; vs. No control group, comparison to baselineEDSS score improvement: no difference (3.8%); Other disability scales: worsened (increased significantly); Patient-reported stability: no difference (47.4%)
37 Collongues et al. 2021cohort study · 48 participantsHigh-dose pharmaceutical-grade biotin (MD1003); 1 year; vs. No control group, before/after observationClinical response (EDSS, 25FWT, 9HPT): improved (13 patients (27%)); Brain volume gain: improved (7/24 patients); Cervical spinal cord volume gain: improved (10/19 patients)

Further studies in this area: 38 46 80 81 94 95 99 100 104 110 111 112 114 115 116 117

Biotin (Vitamin B7) and Hair Loss: Human Studies

A systematic review found three studies on biotin in hair loss; the most informative, placebo-controlled one showed no difference in hair growth 4. With biotin from a plant extract, with or without silica, hair loss decreased in a placebo-controlled study compared with baseline 8. A hair product for application with Redensyl, saw palmetto and biotin performed better together with platelet-rich plasma than Procapil with platelet-rich plasma 12. Injections with biotin and dexpanthenol from two manufacturers reduced hair loss in both groups; there was no group without biotin 13. In acne patients taking isotretinoin, the proportion of growing hairs increased with additional biotin compared with baseline 18. It remains open whether biotin helps in hair loss mainly in a biotin deficiency.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
4 Yelich et al. 2024systematic reviewOral biotin as a hair supplement; vs. Placebo or control groups in the included studiesHair growth: no difference (no difference between the biotin and placebo groups for hair growth); Hair growth or quality: unclear (neither had striking results in favor of biotin)
8 Patel et al. 2025randomised controlled · 105 participantsBotanical extracts with biotin from Sesbania grandiflora, some with silica from Bambusa arundinacea; 1.25 mg biotin orally; biotin-silica group additionally 21.75 mg silica; 90 days; vs. Placebo (Treatment A)Hair fall: unclear (20.61 ± 14.39 (p < 0.001) in biotin and 15.71 ± 10.8 (p < 0.001) in biotin with silica); Hair growth rate: unclear (0.55 mm/day (p < 0.0001) in biotin and 0.57 mm/day (p < 0.0001) in biotin with silica)
18 Aksac et al. 2021controlled · 60 participantsBiotin 10 mg/day added to isotretinoin; 10 mg/day; 4 months; vs. isotretinoin alone (group A) vs. isotretinoin plus biotin (group B)anagen hair ratio: unclear (P = 0.034); telogen hair ratio: unclear (P = 0.003)
21 Schulpis et al. 2001case seriesBiotin supplementation; 10 mg/day; 45 days of valproic acid treatment; vs. Healthy controls; three valproic acid dose groupsAlopecia: improved
33 Şen et al. 2021cohort study · 156 participantsBiotin 1000 mcg/day; 1000 mcg/day; 3 months (biotin deficiency) or mean 2.5 months (self-initiated); vs. patients with vs. without biotin deficiencydecline in hair loss in biotin deficiency: improved (5 (23%)); decline in hair loss without biotin deficiency: improved (11 (38%)); difference between groups with and without biotin deficiency: no difference (P = .2)
34 Kakunje et al. 2025cross-sectional study · 150 participantsValproate treatment; measurement of serum biotinidase and IL-2; 2-year study period; vs. valproate group vs. control groupfrequency of hair loss: worsened (18 (24%) persons of study cohort compared to 2 (2.66%) among the control group); biotinidase activity with vs. without hair loss: no difference (U = 656.000, P ≤ 0.001); IL-2 distribution study vs. control: no difference (U = 3,395.00, P = 0.025)
43 Starace et al. 2021case series · 25 participantsbiotin alone or with topical minoxidil; vs. no control group, retrospective case seriestreatment effectiveness: improved
44 González et al. 2025study · 22 participantsSerum WS Biotin, water-soluble form of D-biotin; 3 months daily application; vs. no control group (single-arm, pretest-posttest)Modified Pull Test (MPT) – reduced hairs: improved (reduced by 43.0% at D30, 56.0% at D60, and 76.1% at D90); Modified Hair Wash Test (MHWT) – vellus hairs (<3 cm): improved (significantly reduced by 90.6% at D30, 67.0% at D60, and 74.8% at D90); MHWT – pulled hairs >3 cm: unclear (significantly diminished by 69.4% at D60 and 60.0% at D90. Contrarily, a significant increase of 227.5% was recorded at D30)

Further studies in this area: 87 96 102 109

Biotin (Vitamin B7), Skin and Skin Inflammation: Human Studies

In acne patients taking isotretinoin, skin moisture decreased significantly without biotin, but not with additional biotin; a direct group comparison was not reported 18. With biotin from a plant extract, with or without silica, skin elasticity increased from baseline in a placebo-controlled study 8. Both studies are small, one was not randomized, and neither reports a direct comparison with the control group. It remains open whether the effects also occur in individuals with adequate biotin status without concomitant medications.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
8 Patel et al. 2025randomised controlled · 105 participantsBotanical extracts with biotin from Sesbania grandiflora, some with silica from Bambusa arundinacea; 1.25 mg biotin orally; biotin-silica group additionally 21.75 mg silica; 90 days; vs. Placebo (Treatment A)Skin elasticity: unclear (0.15 ± 0.06 (p < 0.0001) in biotin and 0.17 ± 0.12 (p < 0.0001) in biotin with the silica group)
18 Aksac et al. 2021controlled · 60 participantsBiotin 10 mg/day added to isotretinoin; 10 mg/day; 4 months; vs. isotretinoin alone (group A) vs. isotretinoin plus biotin (group B)skin hydration: unclear (P = 0.43); skin sebum: no difference; skin retraction: no difference
21 Schulpis et al. 2001case seriesBiotin supplementation; 10 mg/day; 45 days of valproic acid treatment; vs. Healthy controls; three valproic acid dose groupsSeborrheic rash: improved
52 Ting et al. 2025case series · 5 participantsBiotin supplementation; 10-30 mg daily; vs. no control groupSkin rashes: unclear (All patients had skin rashes)
59 Pi et al. 2025case series · 2 participantsOral multivitamin regimen with biotin, lipoic acid, and pantothenic acid; vs. No control group; before-and-after course in patient 2Skin lesions on the fingers: improved (resolution of skin lesions on the fingers)
86 Yılmaz et al. 2024cross-sectional studyBiotinidase enzyme activity and BTD gene analysis; vs. genotype-phenotype correlations, no treatment groupsgenotype-phenotype correlation cutaneous symptoms: unclear (The c.1270G > C variant was most common in patients with cutaneous symptoms)
108 Januszewski et al. 2023reviewBiotin among 13 other nutritional supplementsPhotoprotective effect: improved; Inflammatory skin diseases (atopic dermatitis, psoriasis): improved

Biotin (Vitamin B7), Glucose and Lipid Metabolism: Human Studies

In adults with type 2 diabetes, total cholesterol fell with biotin in a meta-analysis; the reduction in fasting blood glucose and triglycerides was not statistically confirmed, insulin remained unchanged 2. For mixtures of biotin and chromium picolinate, two randomized controlled studies reported improvements in blood glucose and lipid values in type 2 diabetes, but these findings apply to the mixture and not to biotin alone 614. In the meta-analysis, only the reduction in total cholesterol is confirmed; whether biotin alone lowers blood glucose must be clarified by larger studies.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
2 Zhang et al. 2022meta-analysis · 445 participantsBiotin supplementation; 28 to 90 days; vs. Control groups of included RCTsFasting blood glucose: no difference (MD: -1.21 mmol/L, 95% CI: -2.73 to 0.31); Total cholesterol: improved (MD: -0.22 mmol/L, 95% CI: -0.25 to -0.19); Triglycerides: no difference (MD: -0.59 mmol/L, 95% CI: -1.21 to 0.03)
3 Chai et al. 2025systematic reviewWater-soluble vitamins, including biotinGlycemic control and insulin resistance: unclear
19 Marshall et al. 1980controlled · 40 participantsBiotin supplementation; 0.9 mg/day; 71 days; vs. PlaceboTotal plasma lipids: unclear (small but statistically significant positive changes); Total plasma phospholipids: unclear (small but statistically significant positive changes); Alpha + beta lipoprotein cholesterol: unclear (small but statistically significant positive changes)
24 Belda et al. 2022study · 1,545 participantsBiotin plus fructo-oligosaccharides (prebiotics); vs. high-fat diet-fed mice without supplementationweight gain and glycaemic deterioration: improved (limiting weight gain and glycaemic deterioration)
66 Walimbe et al. 2025case report · 1 participantsTargeted replacement with biotin, lipoic acid and pantothenic acidMetabolic control: improved
92 Güder et al. 2023cross-sectional studybiotin (level measurement, no supplementation); vs. no control group, correlationsbiotin levels and cholesterol/triglyceride ratio: unclear (r=0.314); biotin levels and triglyceride levels: unclear (r=-0.315)
98 Mehta et al. 2026reviewBiotin and/or chromium supplements; vs. Single versus combined supplementation, controls (qualitative)Fasting blood glucose, HbA1c, insulin resistance: improved (modest but significant improvements); Lipid parameters: improved (modest but significant improvements); Oxidative stress markers: improved (improve oxidative stress markers)

Biotin (Vitamin B7) and Brittle Nails: Human Studies

With biotin from a plant extract, with or without silica, nail roughness decreased from baseline in a placebo-controlled study with 105 participants 8. A review names biotin alongside collagen peptides, keratin, MSM, and orthosilicic acid among substances that may improve the appearance, strength, and brittleness of nails 105. The certainty of evidence is unclear because only one controlled study is available, which does not report a comparison with placebo, and it remains open whether the participants had a biotin deficiency.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
8 Patel et al. 2025randomised controlled · 105 participantsBotanical extracts with biotin from Sesbania grandiflora, some with silica from Bambusa arundinacea; 1.25 mg biotin orally; biotin-silica group additionally 21.75 mg silica; 90 days; vs. Placebo (Treatment A)Nail roughness: unclear (0.09 ± 0.29 (p < 0.0001) in biotin and 0.06 ± 0.25 (p < 0.0001) in biotin with silica)
97 Fernández-Campos et al. 2020studyRegenail® nail lacquer with biotin, MSM, dimethylsilanediol salicylate; vs. Betalfatrus® reference productReduction in nail alterations (Beau's lines, onychorrhexis): improved; Reduction in surface roughness: improved; Biotin absorption in hooves: improved
105 Zaraa et al. 2025reviewBiotin (dietary supplement)clinical appearance, strength and brittleness of nails: improved

Biotin (Vitamin B7): Further Outcomes in Studies

In children with asthma, biotin in addition to standard therapy reduced the inflammatory markers TNF-α and 8-OHdG more than placebo; lung function improved only with L-carnitine 11. The other works in this area are predominantly observational studies or investigate biotin in combination products; controlled studies on clinical endpoints are still pending here.

StudyDesign · participantsPreparation · dose · duration · comparisonResult
1 Espiritu et al. 2021meta-analysis · 889 participantsHigh-dose biotin (MD1003), oral, as adjunctive treatment; at least 300 mg/day; 12 to 15 months; vs. PlaceboIncidence of any adverse events (RR 0.98; 95% CI 0.92-1.04); Any serious adverse events (RR 0.98; 95% CI 0.77-1.24); Laboratory test interference (31 patients (4.7%))
10 Hanson et al. 2026randomised controlled · 80 participantsPrenatal multivitamin with 150 µg (intervention) or 30 µg (control) biotin; 150 µg vs. 30 µg biotin daily; 24 weeks; vs. Low-dose biotin (30 µg) in the same multivitaminMaternal cortisol: improved (p = 0.04); Association biotin–cortisol (maternal and cord blood): unclear (p < 0.05); Association biotin–osteocalcin in cord blood: unclear (β = 0.013, p = 0.044)
11 Khedr et al. 2026randomised controlled · 66 participantsBiotin 5 mg capsules twice daily plus standard therapy; 5 mg twice daily; 3 months; vs. Placebo plus standard therapySerum TNF-α: improved (P = 0.008); Serum 8-OHdG: improved (P = 0.012); Serum TGF-β1: no difference (P = 0.028)
23 Kong et al. 2025cohort study · 144,439 participantsDietary biotin intake (24-h Oxford WebQ); median 14.06 years follow-up; vs. Q1 (lowest intake) vs. Q2-Q4risk of anxiety or depression: improved (HR: 0.86 [0.82, 0.91] for Q2; HR: 0.84 [0.79, 0.88] for Q3; HR: 0.86 [0.81, 0.91] for Q4); dose-response relationship (RCS): improved (approximately "L-shaped")
24 Belda et al. 2022study · 1,545 participantsBiotin plus fructo-oligosaccharides (prebiotics); vs. high-fat diet-fed mice without supplementationmicrobiome diversity and bacterial biotin production: improved (improves not only the microbiome diversity, but also the potential of bacterial production of biotin and B vitamins)
26 Upadia et al. 2025cohort study · 478 participantsNewborn screening for inborn errors of metabolism, including biotinidase deficiency; January 2005 to December 2024False-positive rate of screening: unclear (0.93%); Deaths: unclear (at least 11 patients died); Adverse neurodevelopmental outcomes (45.7%)
36 Jaafar et al. 2025cross-sectional study · 50 participantsBiotin (serum and follicular fluid levels, no supplementation); vs. Normal, poor, and hyper-respondersBiotin in serum and follicular fluid by ovarian response: no difference; Correlation of follicular biotin with AMH: unclear (p = 0.033); Correlation of follicular biotin with BMI: unclear (p = 0.022)
39 Saudubray et al. 1984case series · 41 participantsVitamin mixture with biotin, thiamine, B12, riboflavin; biotin 10 mg; vs. comparison with similar reported casesvitamin responsiveness in neonatal defects: unclear (very rarely vitamin responsive)

Further studies in this area: 40 42 47 48 51 52 53 54 55 56 57 58 59 60 63 64 66 67 68 69 70 71 72 73 74 75 76 77 78 82 85 86 88 89 90 91 92 93 99 100 101 106 107 113 118

4. How Is Biotin (Vitamin B7) Dosed? Preparation, Dose and Duration in Studies

The studies mostly used oral biotin: as a dietary supplement, high-dose as a drug (MD1003) in multiple sclerosis or in combination products with other vitamins, minerals or plant extracts. Biotin was injected together with dexpanthenol in hair loss 13, applied in a hair product with Redensyl and saw palmetto 12. The doses and dosage forms are listed in the table.

Preparation or formDoseDurationStudy
Chromium picolinate plus biotin (CPB)600 µg chromium and 2 mg biotin once daily90 days6
MD1003 (high-dose biotin)100 mg biotin thrice daily12 months double-blind, then 12 months open-label for all7
Botanical extracts with biotin from Sesbania grandiflora, some with silica from Bambusa arundinacea1.25 mg biotin orally; biotin-silica group additionally 21.75 mg silica90 days8
MD1003 (high-dose pharmaceutical-grade biotin)300 mg/day orally6 months double-blind, then 6 months open-label9
Prenatal multivitamin with 150 µg (intervention) or 30 µg (control) biotin150 µg vs. 30 µg biotin daily24 weeks10
Biotin 5 mg capsules twice daily plus standard therapy5 mg twice daily3 months11
Topical redensyl, saw palmetto, and biotin plus PRP—four sessions at three-week intervals12
Weekly injections of biotin 5 mg/1 ml plus dexpanthenol 250 mg/2 mlBiotin 5 mg plus dexpanthenol 250 mg weekly6 weeks treatment, follow-up at 1 and 8 weeks13
Chromium picolinate and biotin (CPB) or placebo—4 weeks14
Biotin supplement or placebo300 µg (1.2 µmol) biotin per day14 days15
SPP1 specialized food product with biotin and other vitamins2 portions of SPP1 per day14 days16
AG1, comprehensive nutritional supplement with vitamins, minerals, probiotics, phytochemicalsSingle serving 13 g mixed in waterSingle dose, 1-week washout17
Biotin 10 mg/day added to isotretinoin10 mg/day4 months18
Biotin supplementation0.9 mg/day71 days19
Biotin supplement10 mg/d—20

5. Is Biotin (Vitamin B7) Safe? Side Effects in Studies

Adverse events with high-dose biotin in multiple sclerosis occurred no more frequently than with placebo 179; in children with asthma, biotin proved to be safe 11. However, high-dose biotin distorted laboratory tests in some of those treated, and in no one with placebo 1.

StudyReported side effects
1 Espiritu et al. 2021Any and serious AEs not different; laboratory test interference in 4.7% on biotin
6 Albarracin et al. 2007well tolerated, no adverse effects, similar to placebo
7 Tourbah et al. 2016Safety profile similar to placebo
8 Patel et al. 2025No adverse events reported
9 Tourbah et al. 2018Safety profile similar to placebo
11 Khedr et al. 2026Biotin was safe
13 Samadi et al. 2022Adverse drug reactions recorded; treatment described as safe
14 Geohas et al. 2007No significant adverse events in either group
16 2021Product well tolerated
17 Sapp et al. 2026Both well tolerated, no serious adverse events
18 Aksac et al. 2021biotin prevented mucocutaneous adverse effects of isotretinoin
21 Schulpis et al. 2001Skin lesions (seborrheic rash, alopecia) improved with biotin

6. What Remains Open: Limits of the Evidence

  • Most controlled studies are small and short; large long-term studies are still pending.
  • Whether the findings for hair, skin and nails are tied to a biotin deficiency is an open question.
  • Many findings come from combination products and apply to the mixture, not to biotin alone.
  • In multiple sclerosis, the results are inconsistent and only some of the endpoints were investigated.
  • For most uses, controlled studies with clinical endpoints are still pending.

7. Bottom Line: What Is Established About Biotin (Vitamin B7)

Biotin is a water-soluble B vitamin that, as a coenzyme of several carboxylases, is involved in fat, carbohydrate and protein metabolism. In type 2 diabetes, biotin lowered total cholesterol in a meta-analysis; the effect on blood glucose is not yet confirmed. For hair, skin and nails, measured values improved in small studies mainly compared with baseline; the most informative placebo-controlled hair study found no difference. Many positive results come from combination products and therefore do not apply to biotin alone. In progressive multiple sclerosis, high-dose biotin showed benefit in an initial study, and the follow-up study did not confirm it. In signs of biotin deficiency, such as in pregnancy, biotin improved biotin-dependent metabolic values. Biotin was well tolerated; in high doses it can distort laboratory tests.

Frequently Asked Questions

How well has Biotin (Vitamin B7) been studied in humans?

We evaluated 123 human studies on Biotin (Vitamin B7), including 12 randomised controlled trials and 6 meta-analyses or systematic reviews; the controlled studies include 1,170 participants in total. As of 11 October 2026.

Does Biotin (Vitamin B7) help with biotin deficiency? What the studies show

We evaluated 3 controlled studies and 24 further studies; the controlled studies include 128 participants in total. Result of the controlled studies: mostly improved. Strength of evidence under our published rules: moderate. Sources: 10152022

Does Biotin (Vitamin B7) help with multiple sclerosis? What the studies show

We evaluated 2 meta-analyses or systematic reviews, 2 controlled studies and 20 further studies; the controlled studies include 247 participants in total. Result of the controlled studies: mostly no difference. Strength of evidence under our published rules: low. Sources: 1579

Does Biotin (Vitamin B7) help with hair loss? What the studies show

We evaluated one meta-analysis or systematic review, 2 controlled studies and 9 further studies; the controlled studies include 165 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: unclear. Sources: 481821

Does Biotin (Vitamin B7) help with skin and skin inflammation? What the studies show

We evaluated 2 controlled studies and 5 further studies; the controlled studies include 165 participants in total. Result of the controlled studies: mostly no difference. Strength of evidence under our published rules: unclear. Sources: 8182152

Does Biotin (Vitamin B7) help with glucose and lipid metabolism? What the studies show

We evaluated one meta-analysis or systematic review, one controlled study and 5 further studies; the controlled studies include 40 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: unclear. Sources: 231924

Does Biotin (Vitamin B7) help with brittle nails? What the studies show

We evaluated one controlled study and 2 further studies; the controlled studies include 105 participants in total. Result of the controlled studies: mixed. Strength of evidence under our published rules: unclear. Sources: 897105

What is biotin and what is it needed for in the body?

Biotin is a water-soluble vitamin from the group of B vitamins. In the body it acts as a coenzyme of several carboxylases that are involved in fat, carbohydrate and protein metabolism. Medically it is given in confirmed biotin deficiency and in congenital disorders of biotin metabolism.

Do human studies show an effect of biotin on hair loss?

A systematic review found three studies on biotin in hair loss; the most informative, placebo-controlled one showed no difference in hair growth 4. For biotin from a plant extract and for combination products with biotin, improvements were reported, but only compared with baseline or another hair product 81213.

How does biotin affect blood glucose and lipid metabolism?

In adults with type 2 diabetes, total cholesterol fell with biotin in a meta-analysis; the reduction in fasting blood glucose and triglycerides was not statistically confirmed, insulin remained unchanged 2. For mixtures of biotin and chromium picolinate, two randomized controlled studies reported improvements in blood glucose and lipid values, but these findings apply to the mixture and not to biotin alone 614.

What role does biotin play in multiple sclerosis?

In multiple sclerosis, high-dose biotin (MD1003) was tested against placebo in several randomized studies 7925. In a randomized study in progressive MS, disability regressed in some patients with high-dose biotin, and in no one with placebo 7. The follow-up study SPI2 did not confirm this benefit 25. Another randomized controlled study showed no difference in visual acuity, nerve fiber layer thickness and quality of life in MS-related chronic vision loss 9. A systematic review with meta-analysis found no confirmed difference from placebo in disability and EDSS, but more often a faster walking time 1.

Is biotin safe and what side effects are known?

Adverse events with high-dose biotin in multiple sclerosis occurred no more frequently than with placebo 179; in children with asthma, biotin proved to be safe 11. However, high-dose biotin distorted laboratory tests in some of those treated, and in no one with placebo 1.

Sources

  1. 1
  2. 2
  3. 3
  4. 4
    Biotin for Hair Loss: Teasing Out the Evidence
    Yelich A, Jenkins H, Holt S, Miller R · 2024
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
    Mock DM, Quirk JG, Mock NI · 2002
  16. 16
    New Specialized Food Product “SPP1” in Combination With Iso-Calorie Diet Shows Better Efficacy Than the Diet Alone in Treatment of Non-alcoholic Steatohepatitis
    · 2021
  17. 17
  18. 18
  19. 19
    Effects of biotin on lipids and other constituents of plasma of healthy men and women
    Marshall MW, Kliman PG, Washington VA, Mackin JF, Weinland BT · 1980
  20. 20
  21. 21
    Schulpis KH, Karikas GA, Tjamouranis J, Regoutas S, Tsakiris S · 2001
  22. 22
    Jezela-Stanek A, Suchoń L, Sobczyńska-Tomaszewska A, Czerska K, Kuśmierska K, Taybert J et al. · 2022
  23. 23
  24. 24
  25. 25
    Joseph GB, McCune M, Bove R, Abdelhak A, Cree BAC, Block VJ · 2026
  26. 26
  27. 27
    Sharma R, Kucera CR, Nery CR, Lacbawan FL, Salazar D, Tanpaiboon P · 2024
  28. 28
    Yaralı O, Arslan S, Gündoğdu Öğütlü ÖB, Guler MC, Akgül BN · 2024
  29. 29
  30. 30
    Gülbahçe A, Muderrisoglu A, Güneş H, Erdoğan M, Dündar M, Kardaş F · 2026
  31. 31
  32. 32
    Couloume L, Barbin L, Leray E, Wiertlewski S, Le Page E, Kerbrat A et al. · 2020
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
    Saudubray JM, Ogier H, Charpentier C, Depondt E, Coudé FX, Munnich A et al. · 1984
  40. 40
    Mohammed M, El Agouza I, Zaitoun R, Ahmad K, Mohammad S, Sallam O et al. · 2026
  41. 41
  42. 42
    Himmelreich N, Garbade SF, Okun JG, Hengst S, Geiger V, Barone R et al. · 2026
  43. 43
    Starace M, Gurioli C, Carpanese MA, Bruni F, Piraccini BM, Patrizi A et al. · 2021
  44. 44
  45. 45
  46. 46
    Guillevin C, Agius P, Naudin M, Herpe G, Ragot S, Maubeuge N et al. · 2019
  47. 47
  48. 48
    Biswas A, McNamara C, Gowda VK, Gala F, Sudhakar S, Sidpra J et al. · 2023
  49. 49
    Moatter T, Ahmed S, Majid H, Jafri L, Bilal M, Najumuddin et al. · 2024
  50. 50
  51. 51
    Seilanian Toosi F, Saberifar M, Ahangari N, Hashemi N, Beiraghi Toosi M · 2026
  52. 52
  53. 53
  54. 54
  55. 55
    Ortigoza-Escobar JD, Serrano M, Molero M, Oyarzabal A, Rebollo M, Muchart J et al. · 2014
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
    Greenway FL, Ingram DK, Ravussin E, Hausmann M, Smith SR, Cox L et al. · 2011
  61. 61
  62. 62
    Sharma R, Bhatti A, Singh D, Kapoor N, Bharathiraja S, Kaul S et al. · 2026
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
    Tse J, Abu-Qamar A, Youssef O, Pejka SL · 2025
  72. 72
  73. 73
  74. 74
    Chodnicki KD, Aksamit AJ, Gavrilova RH, Farnsworth PJ, McClelland CM · 2024
  75. 75
  76. 76
    Abdi F, Parvin S, Zare Hosseinabadi V, Kachuei M, Gordiz A, Hemmati S et al. · 2024
  77. 77
    Gowda VK, Avaragollapuravarga Mathada A, Srinivasan VM, Vamyanmane DK · 2023
  78. 78
  79. 79
    Geng J, Sun Y, Zhao Y, Xiong W, Zhong M, Zhang Y et al. · 2021
  80. 80
    Demas A, Cochin JP, Hardy C, Vaschalde Y, Bourre B, Labauge P · 2020
  81. 81
    Lebrun C, Cohen M, Mondot L, Ayrignac X, Labauge P · 2017
  82. 82
    Ünlü Torlak E, Koç Yekedüz M, Bülbül YE, Kara İS, Erdoğan Kablan S, Eylem CC et al. · 2026
  83. 83
  84. 84
  85. 85
  86. 86
    Yılmaz B, Ceylan AC, Gündüz M, Ünal Uzun Ö, Küçükcongar Yavaş A, Bilginer Gürbüz B et al. · 2024
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
    Mathais S, Moisset X, Pereira B, Taithe F, Ciron J, Labauge P et al. · 2021
  95. 95
  96. 96
    Biotin Deficiency in Telogen Effluvium: Fact or Fiction?
    Abdel Rahman SH, Mohammed Salem R, Hassan Sabry J · 2020
  97. 97
    Fernández-Campos F, Navarro F, Corrales A, Picas J, Pena E, González J et al. · 2020
  98. 98
  99. 99
  100. 100
    Aguilera-Méndez A, Aguilera-Manuel K, Saavedra-Molina A, Ríos-Chávez P, Villafaña S, Nieto-Aguilar R et al. · 2026
  101. 101
  102. 102
    Troshina EA, Suplotova LA, Dzgoeva FK, Ruyatkina LA, Gadzhigoroeva AG, Gromova OA et al. · 2026
  103. 103
    Biotinidase Deficiency
    Woodliff B, Benjamin R, Simpson B · 2025
  104. 104
    Rajabi M, Shafaeibajestan S, Asadpour S, Alyari G, Taei N, Kohkalani M et al. · 2025
  105. 105
    Zaraa I, Richert B · 2025
  106. 106
  107. 107
  108. 108
    Januszewski J, Forma A, Zembala J, Flieger M, Tyczyńska M, Dring JC et al. · 2023
  109. 109
    Praharaj SK, Munoli RN, Udupa ST, Vaidyanathan S · 2022
  110. 110
    Bisaga GN, Mikhailenko AA, Barsukov IN · 2019
  111. 111
  112. 112
  113. 113
  114. 114
  115. 115
  116. 116
  117. 117
    Intersections of pathways involving biotin and iron relative to therapeutic mechanisms for progressive multiple sclerosis
    Heidker RM, Emerson MR, LeVine SM · 2016
  118. 118
    Biotin-Thiamine-Responsive Basal Ganglia Disease
    Tabarki B, Al-Hashem A, Ortigoza-Escobar JD, Alsharhan H, Alfadhel M · 1993

Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.

International Health Research · https://ih-research.com/en/knowledge/biotin/ · Last updated: 2026-10-15